Novartis Investigative Site

Lisbon, Portugal 1769-001

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction, Rheumatoid Arthritis, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents. — Stopped early
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early